-+ 0.00%
-+ 0.00%
-+ 0.00%

XENON PHARMACEUTICALS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $63 FROM $50

Reuters·03/16/2026 10:59:00

Please log in to view news